Company Directory / investment management
PrivateFor profitinvestment managementPittsburgh, United States
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
- Founded
- 2004 22 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $164M as listed, currency not stated
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
22 years old.
Reach
No web traffic ranking listed.
What it does
BiotechnologyHealth CareHealth DiagnosticsMedical
Funding, as listed
$164M currency not stated
- Rounds10
- LatestSeries c, Nov 2020
- Investors6, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Knopp Biosciences, field by field. Contact details are held but never shown.
The company
- Name
- Knopp Biosciences
- Type
- For profit
- Status
- Private
- Founded
- 2004
- Founders
- Gregory Hebrank, Robert Bowser Ph.D.
- Industry
- investment management
- Categories
- Biotechnology, Health Care, Health Diagnostics, Medical
Where
- City
- Pittsburgh
- Country
- United States
- Markets
- Great Lakes, Northeastern US
Size and reach
- Staff band
- 1-10
Funding, as listed
- Total
- 164,029,814 (currency not stated)
- Rounds
- 10
- Latest round
- Series c
- Latest round date
- Nov 2020
- Investors
- 6
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Knopp Biosciences may be growing as indicated by several pieces of evidence from recent news articles. The company has been involved in funding research, as one article discloses that work was funded by Knopp Biosciences, suggesting an investment in research and development. Additionally, there is mention of an acquisition where Knopp Biosciences LLC was acquired by another entity in April 2022, which could indicate a strategic move to enhance its financial and operational capabilities. Furthermore, Knopp Biosciences is listed alongside other companies in a report on the tinnitus drug pipeline market, implying active participation in new drug development within its industry.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
investment management in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.